Ortho Clinical Diagnostics Holdings PLC OCDX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:04 PM EDT
17.64UNCH (UNCH)
Volume
84,408
Close
17.64quote price arrow down-0.40 (-2.22%)
Volume
1,116,118
52 week range
16.04 - 22.99
Loading...
  • Open17.91
  • Day High18.20
  • Day Low17.59
  • Prev Close18.04
  • 52 Week High22.99
  • 52 Week High Date06/14/21
  • 52 Week Low16.04
  • 52 Week Low Date02/17/22

Key Stats

  • Market Cap4.194B
  • Shares Out237.73M
  • 10 Day Average Volume1.16M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-17.53

KEY STATS

  • Open17.91
  • Day High18.20
  • Day Low17.59
  • Prev Close18.04
  • 52 Week High22.99
  • 52 Week High Date06/14/21
  • 52 Week Low16.04
  • 52 Week Low Date02/17/22
  • Market Cap4.194B
  • Shares Out237.73M
  • 10 Day Average Volume1.16M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-17.53

RATIOS/PROFITABILITY

  • EPS (TTM)-0.01
  • P/E (TTM)-3,266.67
  • Fwd P/E (NTM)20.61
  • EBITDA (TTM)508.90M
  • ROE (TTM)-0.10%
  • Revenue (TTM)2.036B
  • Gross Margin (TTM)50.49%
  • Net Margin (TTM)-0.02%
  • Debt To Equity (MRQ)505.37%

EVENTS

  • Earnings Date08/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ortho Clinical Diagnostics Holdings PLC

There is no recent news for this security.

Profile

MORE
Ortho Clinical Diagnostics Holdings PLC is an in vitro diagnostics (IVD) diagnostic company. The Company provides laboratory testing and blood-typing solutions to the clinical laboratory and transfusion medicine communities. The Company provides customized solutions for clinical outcomes, lab performance and staffing challenges. The Company operates through two lines of business such as Clinical Laboratories and Transfusion Medicine. Its Clinical Laboratories business focuses...
Chris Smith
Chairman of the Board, Chief Executive Officer
Chad Dale
Chief Operating Officer
Joseph Busky
Chief Financial Officer
Michael Schlesinger
Executive Vice President, General Counsel, Company Secretary
Michael Iskra
Executive Vice President of Commercial Excellence & Strategy
Address
1001 Route 202
Raritan, NJ
08869
United States

Top Peers

SYMBOLLASTCHG%CHG
IART
Integra Lifesciences Holdings Corp
59.79-2.54-4.08%
MMSI
Merit Medical Systems Inc
60.69-1.55-2.49%
ITGR
Integer Holdings Corp
74.64-0.78-1.03%
NUVA
NuVasive Inc
54.40-1.42-2.54%
HAE
Haemonetics Corp
59.04-0.84-1.40%